Water-Soluble Palladium Reagents for Cysteine S-Arylation under Ambient Aqueous Conditions.

We report the use of a sulfonated biarylphosphine ligand (sSPhos) to promote the chemoselective modification of cysteine containing proteins and peptides with palladium reagents in aqueous medium. The use of sSPhos allowed for the isolation of several air-stable and water-soluble mono- and bis-palladium reagents, which were used in an improved protocol for the rapid S-arylation of cysteines under benign and physiologically relevant conditions. The cosolvent-free aqueous conditions were applied to the conjugation of a variety of biomolecules with affinity tags, heterocycles, fluorophores, and functional handles. Additionally, bis-palladium reagents were used to perform macrocyclization of peptides bearing two cysteine residues.

[1]  S. Buchwald,et al.  General catalysts for the Suzuki-Miyaura and Sonogashira coupling reactions of aryl chlorides and for the coupling of challenging substrate combinations in water. , 2005, Angewandte Chemie.

[2]  D. Spring,et al.  Peptide stapling techniques based on different macrocyclisation chemistries. , 2015, Chemical Society reviews.

[3]  Alexander M. Spokoyny,et al.  Rapid Flow‐Based Peptide Synthesis , 2014, Chembiochem : a European journal of chemical biology.

[4]  D. Spring,et al.  Functionalised staple linkages for modulating the cellular activity of stapled peptides , 2014 .

[5]  Gonçalo J L Bernardes,et al.  Advances in chemical protein modification. , 2015, Chemical reviews.

[6]  Alexander M. Spokoyny,et al.  Organometallic Palladium Reagents for Cysteine Bioconjugation , 2015, Nature.

[7]  S. Buchwald,et al.  Divergent unprotected peptide macrocyclisation by palladium-mediated cysteine arylation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6sc05454d Click here for additional data file. , 2016, Chemical science.

[8]  C. Bertozzi,et al.  Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development , 2014, Bioconjugate chemistry.

[9]  H. Pauly.  Über die Konstitution des Histidins. I. Mitteilung. , 1904 .

[10]  Stephen P. Hale,et al.  The exploration of macrocycles for drug discovery — an underexploited structural class , 2008, Nature Reviews Drug Discovery.

[11]  Siegfried S. F. Leung,et al.  Cell-permeable cyclic peptides from synthetic libraries inspired by natural products. , 2015, Journal of the American Chemical Society.

[12]  S. Kent,et al.  Constructing proteins by dovetailing unprotected synthetic peptides: backbone-engineered HIV protease. , 1992, Science.

[13]  L. Vassilev,et al.  Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy , 2013, Proceedings of the National Academy of Sciences.

[14]  Ian Collins,et al.  Macrocycles in new drug discovery. , 2012, Future medicinal chemistry.

[15]  M. Francis,et al.  Using synthetically modified proteins to make new materials. , 2011, Accounts of chemical research.

[16]  M. Brechbiel,et al.  Growing applications of "click chemistry" for bioconjugation in contemporary biomedical research. , 2009, Cancer biotherapy & radiopharmaceuticals.

[17]  B. Pentelute,et al.  Delivery of Antibody Mimics into Mammalian Cells via Anthrax Toxin Protective Antigen , 2014, Chembiochem : a European journal of chemical biology.

[18]  Christopher J. White,et al.  Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.

[19]  N. Stephanopoulos,et al.  Choosing an effective protein bioconjugation strategy. , 2011, Nature chemical biology.